Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2153818rdf:typepubmed:Citationlld:pubmed
pubmed-article:2153818lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:2153818lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:2153818lifeskim:mentionsumls-concept:C0678518lld:lifeskim
pubmed-article:2153818lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:2153818pubmed:issue2lld:pubmed
pubmed-article:2153818pubmed:dateCreated1990-3-9lld:pubmed
pubmed-article:2153818pubmed:abstractTextA series of congeners of hemicholinium-3, in which the 1,4-oxazinium rings of hemicholinium are replaced by pyrrolidine, piperidine, 1,3-dioxane, or 1,4-oxazine rings, is described. Several of the target compounds produced blockade of neuromuscular transmission in the rabbit, and three heterocyclic derivatives, 10, 11, and 13, significantly antagonized paraoxon-induced lethality in mice. 1,3-Dioxane derivative 11 was an extremely potent antagonist of paraoxon-induced toxicity in mice, compared with prototypical protective agents physostigmine and pyridostigmine. Compound 11 exhibited a much more favorable therapeutic ratio than the reference drugs. The mechanism of action of 11 has not been elucidated, although it is concluded that it differs from that of hemicholinium-3 (inhibition of high-affinity, sodium-dependent uptake of choline into nerve terminals).lld:pubmed
pubmed-article:2153818pubmed:languageenglld:pubmed
pubmed-article:2153818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:citationSubsetIMlld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2153818pubmed:statusMEDLINElld:pubmed
pubmed-article:2153818pubmed:monthFeblld:pubmed
pubmed-article:2153818pubmed:issn0022-2623lld:pubmed
pubmed-article:2153818pubmed:authorpubmed-author:NomaSSlld:pubmed
pubmed-article:2153818pubmed:authorpubmed-author:CannonJ GJGlld:pubmed
pubmed-article:2153818pubmed:authorpubmed-author:BhatnagarR...lld:pubmed
pubmed-article:2153818pubmed:authorpubmed-author:FlynnJ RJRlld:pubmed
pubmed-article:2153818pubmed:authorpubmed-author:SahinM FMFlld:pubmed
pubmed-article:2153818pubmed:issnTypePrintlld:pubmed
pubmed-article:2153818pubmed:volume33lld:pubmed
pubmed-article:2153818pubmed:ownerNLMlld:pubmed
pubmed-article:2153818pubmed:authorsCompleteYlld:pubmed
pubmed-article:2153818pubmed:pagination577-9lld:pubmed
pubmed-article:2153818pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:meshHeadingpubmed-meshheading:2153818-...lld:pubmed
pubmed-article:2153818pubmed:year1990lld:pubmed
pubmed-article:2153818pubmed:articleTitleHemicholinium-3 congeners as potential antagonists to organophosphate-induced toxicity.lld:pubmed
pubmed-article:2153818pubmed:affiliationDivision of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City 52242.lld:pubmed
pubmed-article:2153818pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2153818pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2153818pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2153818lld:chembl